MRIGlobal’s CBCS units (view brochure) deployed in ‘Tranquil Shift’
international exercise described by U.S. officials as “the largest
overseas biocontainment exercise in history” was an interagency task
force led by the U.S. Department of State’s director of Operational
Medicine and the U.S. Department of Health and Human Services’ Office of
the Assistant Secretary for Preparedness and Response.
Shift’ assessed the readiness of federal, state, local, and private
partners to respond to an outbreak overseas by testing the U.S.
Government’s maximum lift capability in response to a simulated outbreak
of a highly contagious pathogen.
MRIGlobal’s CBCS Containerized
BioContainment Systems were used to evacuate simulated American patients
to Ebola treatment centers across the United States.
11th, a total of five aircraft – two 747s and three Gulfstream IIIs –
departed Atlanta, Georgia, traveled to Dakar, Senegal, where they
prepared for the evacuation.
On April 12th, all these aircraft
flew to Freetown, Sierra Leone to pick up their patients and flew on to
Washington Dulles Airport to clear customs.
Read the official debrief: April 19, 2017
A key task under the Homeland Defense Technical Area Tasks contract awarded to MRIGlobal will provide innovative work in chemical and biological defense.
Kansas City, Mo. – MRIGlobal was awarded the Research, Development, Test and Evaluation, and Strategic Initiatives task under the Homeland Defense Technical Area Tasks (HD TAT) contract with DTIC on 10 February 2017.
MRIGlobal will provide a broad range of technical services to the defense community to study, analyze, advise, research, and develop deliverables to advance Homeland Defense (HD) related scientific and technical information (STI).
The contract is intended to provide defense researchers and acquisitions teams with access to leading capabilities and experts in Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) defense areas.
"The projects we'll conduct on this task build upon our more than 70 years of expertise supporting our Nation's vital functions protecting us from the continuing CBRNE threat" said Thomas M. Sack, Ph.D., President and Chief Executive Officer, MRIGlobal. "We are excited to begin this new chapter in our work to serve our defense community."
"We have some of the best staff and facilities in the world" said Robert Conklin, Vice-President for Technical Operations, MRIGlobal. "This contract allows us to continue to provide these services to the entire Defense Enterprise."
Biomedical Advanced Research and Development Authority (BARDA)Continues Relationship with MRIGlobal in Nonclincial Studies Network
Kansas City, Mo. – MRIGlobal will continue its relationship with the Biomedical Advanced Research and Development Authority (BARDA) in its mission to support development and acquisition of medical countermeasures to prevent or treat biological threats, pandemic influenza, and emerging infectious diseases.
BARDA's Nonclinical Studies Network (NSN) is a key element in the successful development of medical countermeasures for biological threats.
"We are very pleased to mark seven years as a member of BARDA's Nonclinical Studies Network," said Thomas M. Sack, Ph.D., President and Chief Executive Officer. "We look forward to our continued collaboration."
MRIGlobal will support BARDA's mission by completing studies regulated under the Good Laboratory Practices (GLP) regulations as well as other unregulated studies which will support the advancement of potential life-saving therapeutics and vaccines.
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.
The mission of BARDA is to develop and procure medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases. Specifically, BARDA supports the advanced development and procurement of drugs, vaccines and other products that are considered priorities for national health security through its programmatic initiatives.
Jose Zavala, Ph.D., Wins Travel Scholarship to Present Research at Conference.
MRIGlobal is proud to announce the winner of its travel award to attend the annual conference of the Society of Toxicology (SOT) Conference in Baltimore.
Jose Zavala, Ph.D., is performing his post doctorate research training work at the U.S. Environmental Protection Agency.
At the conference, Dr. Zavala presented his research, "Gas-phase mutagenicity in salmonella of 12 distinct simulated smog atmospheres generated using environmental irradiation chambers."
Dr. Zavala was introduced at a special Hispanic Organization of Toxicologists event by Robert P. Casillas, Ph.D., Vice President, Strategic Global Health Security, MRIGlobal.
The travel award was presented March 14 at the Hispanic Organization Annual Reception at the conference.
The SOT 56th Annual Meeting and ToxExpo, held March 12-16, 2017, is the world's largest forum to showcase discoveries and achievements in toxicology research. More than 6,800 of the world's leading researchers and scientists and toxicologists from academia, government, and industry participate in lectures, training, and scientific sessions.
Public event will showcase Paseo/MRIGlobal's 11th FIRST Robotics season.
Kansas City, Mo. – MRIGlobal will host an open house from 3 to 5 p.m. on Monday, February 20, 2017, for the FIRST robotics team from Paseo Academy of Fine and Performing Arts. The event will take place in the MRIGlobal Mag Auditorium, 4920 Cherry St.
This is the eleventh year MRIGlobal has sponsored, mentored, and coached Paseo Academy's FIRST Robotics program.
Monday's event is free and open to the public. Parking is available at the auditorium, which is on the grounds of the MRIGlobal headquarters.
Paseo's robot will compete in the FIRST Regional Robotics Competition March 17-18 at Metropolitan Community College Business and Technology Center, 1775 Universal Avenue, Kansas City, Missouri. The competition is free to attend.
FIRST Robotics was launched by inventor and founder, Dean Kamen.
MRIGlobal awarded top prize at Feb. 9 event.
Kansas City, Mo. – MRIGlobal was named Healthiest Employer in Kansas City Business Journal's Healthiest Employers competition (100-499 category).
MRIGlobal offers staff on-site wellness coaching, wellness room, nutrition programs, and dozens of programs each year. In 2016, the wellness room was remodeled to include a massage area and the recreation room was added to accommodate playing darts or pingpong.
For decades, MRIGlobal has maintained an on-site gym with an indoor basketball court, an array of fitness equipment, weights, and locker rooms. Outside, there are facilities for sand volleyball and touch football, plus a terraced amphitheater and access to great running/walking trails. During lunch and before and after work, MRIGlobal provides employees and their families with many types of free fitness classes.
This year, 22 companies with local offices made the finalist cut, based on wellness programming and benefits.
Competing employers were split into categories by global workforce size. Healthiest Employers LLC, a data research company, measured those factors. The assessment scored organizations on the wellness program's culture and leadership commitment, foundational components, strategic planning, communication and marketing, programming and interventions, and reporting and analysis.
ASM BIOTHREATS: Research, Response, and Policy Conference is Feb. 6-8 in Washington, D.C.
Kansas City, Mo. – MRIGlobal will present an interactive session entitled, "The Role of Genomics in Emerging Infectious Disease Surveillance" at the 2017 ASM Biothreats: Research, Response, and Policy meeting on February 7 in Washington, D.C.
Moderated by MRIGlobal Chief Science Advisor, Chris Detter, Ph.D., the session features experts in One Health Surveillance approaches and practice; science and technology (pathogen genomics and bioinformatics); and regulatory compliance and public health policy implications of pathogen genomics.
MRIGlobal will also showcase technical poster presentations:
- Ultraportable Technologies for OnSite Arbovirus Surveillance from Mosquitos: Bringing the Lab to the Sample
- Development and Implementation of Ebola Virus Disease Diagnostics Training in West Africa
The meeting runs from February 6-8 and was formerly known as the ASM Biodefense and Emerging Diseases Research Meeting. The 2017 ASM Biothreats: Research, Response, and Policy meeting is sponsored by the American Society for Microbiology. Held at Marriott Wardman Park, the conference will discuss a wide range of biological threats and emerging infectious diseases to stimulate knowledge-sharing amongst stakeholders in academia, industry and government and help the overlapping communities prepare for, mitigate, and prevent these global threats. The event covers relevant topics in basic and applied research; public health, emergency response and preparedness; and biosecurity, government, and policy responses.
About the American Society for Microbiology
The American Society for Microbiology (ASM) is the largest single life science society, composed of over 47,000 scientists and health professionals. ASM's mission is to promote and advance the microbial sciences.
ASM advanced the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of microbial sciences to diverse audiences.
MRIGlobal is one of seven finalists; first-place winners to be announced Feb. 9.
Kansas City, Mo. – MRIGlobal has been named a finalist in the Kansas City Business Journal's Healthiest Employers awards program. MRIGlobal's Wellness Works offers staff on-site wellness coaching, wellness room, nutrition programs, and dozens of programs each year.
For decades, MRIGlobal has maintained an on-site gym with an indoor basketball court, an array of fitness equipment, weights, and locker rooms. Outside, there are facilities for sand volleyball and touch football, plus a terraced amphitheater and access to great running/walking trails. During lunch and before and after work, MRIGlobal provides staff and their families with many types of free fitness classes.
MRIGlobal is one of seven finalists in the award category for 100-499 employees. The first-place winners in each category of the Healthiest Employer program will be announced at the award breakfast on Thursday, Feb. 9.
This year, 22 companies with local offices made the cut, based on wellness programming and benefits. Competing employers were split into categories by global workforce size. Healthiest Employers LLC, a data research company, measured those factors. The assessment scored organizations on the wellness program's culture and leadership commitment, foundational components, strategic planning, communication and marketing, programming and interventions, and reporting and analysis.
MRIGlobal will evaluate technologies and specimen processes to support the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH)
Kansas City, Mo. – MRIGlobal has been awarded a contract (Contract No. HHSN272201700001C) from the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to support its Mycobacterium tuberculosis (Mtb) Quality Assessment requirement (known as, “TBQA”).
Under the $13,704,858 (includes the Base Period and all options) contract, MRIGlobal will evaluate Mtb technologies and specimen processes to be used in NIAID-supported clinical investigations and disseminate TBQA technical and scientific data.
Additionally, MRIGlobal will assess the NIAID laboratory network capabilities to accurately and reliably perform study-specific Mtb tests. If any deficiencies are identified, MRIGlobal will advise and train laboratory and clinical site staff.
“We are honored to support NIAID in its research to better understand the development of Tuberculosis drug resistance,” said Roger K. Harris, Ph.D., MRIGlobal Vice President. “The opportunity builds upon our ongoing expertise in global health as it relates to detecting, preventing, and responding to infectious disease and antimicrobial resistance.”
Tuberculosis (TB) is a contagious and often severe airborne disease caused by infection with Mycobacterium tuberculosis bacteria. TB typically affects the lungs, but it can also affect any other organ of the body, and continues to be one of the major causes of disability and death worldwide.
MRIGlobal's Containerized Bio Containment System (CBCS) wins R&D Magazine's R&D 100 Award
Kansas City, Mo. – MRIGlobal's state-of-the-art, flight-ready Containerized Biocontainment System (CBCS) has been awarded an R&D100 Award for Innovation by R&D Magazine. Each year R&D Magazine presents the awards to 100 of the most technologically significant and innovative technologies introduced to the marketplace over the past year.
Effectively addressing global public health challenges, such as Ebola, requires the commitment of medical professionals. A major recruitment challenge has been limited access to medical evacuation should health workers become ill and need access to medical treatment. To help solve this challenge, a $5 million dollar private-public partnership grant between Paul G. Allen and the State Department was established for the development and manufacture of the CBCS.
MRIGlobal designed the CBCS as a reusable bio-containment and medical treatment unit to operate on government/civilian cargo aircraft. Able to fully contain highly-contagious pathogens, the extremely durable and safe CBCS units allow for the secure transport of healthcare workers abroad. The CBCS can treat four critically ill patients while maintaining biocontainment and safe flight.
"The CBCS was designed to save lives," said Dean Gray, Ph.D., Director of Special Programs, MRIGlobal. "There's nothing like this in the world right now and it was developed in response to an urgent need. With CBCS, the world is ready for the next big event."
See the video here: https://youtu.be/RI7WcxRSWhA
Winners were presented with their honors at the 54th Annual R&D Awards dinner on November 3.